Latest News and Press Releases
Want to stay updated on the latest news?
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ASPO Plc STOCK EXCHANGE...
-
SAN DIEGO, March 12, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
-
NEW YORK, March 12, 2015 (GLOBE NEWSWIRE) -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158) ("UBIC" or "the Company"), a leading provider of international litigation support and big-data analysis services,...
-
Fourth Quarter Total Sales Increased 7.3% and Comparable Store Sales Increased 5.6% 11% Increase in Fourth Quarter Adjusted Operating Income Highlights An 11 percent increase in fourth...
-
GUANGZHOU, China, March 12, 2015 (GLOBE NEWSWIRE) -- Sungy Mobile Limited (Nasdaq:GOMO) ("Sungy Mobile" or the "Company"), a leading provider of mobile internet products and services globally with a...
-
U.S. Energy Corp. Reports Fourth Quarter and Year End 2014 Highlights and Selected Financial Results
RIVERTON, Wyo., March 12, 2015 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (Nasdaq:USEG) ("we", "us" or the "Company"), today reported its fourth quarter and year end 2014 highlights and selected financial...
-
LEUVEN, Belgium, March 12, 2015 (GLOBE NEWSWIRE) -- Materialise NV (Nasdaq:MTLS), a leading provider of Additive Manufacturing software and of sophisticated 3D printing solutions in the medical and...
-
NORCROSS, Ga., March 12, 2015 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announces it...
-
TORONTO, March 12, 2015 (GLOBE NEWSWIRE) -- Perk International Inc. (OTCBB:PRKI) wholly owned subsidiary TECH9 Inc., announced today that they have been awarded the contract by IDS (Information...
-
TEL AVIV, Israel, March 12, 2015 (GLOBE NEWSWIRE) -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced today that the U.S. Food and Drug...